Stay updated on Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T10:51:46.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:06:34.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:35:19.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating restricted access. The header and footer of the ClinicalTrials.gov layout remain visible around the error message.
    Difference
    21%
    Check dated 2026-09-19T20:46:15.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Funding information was added under Other Study ID Numbers to indicate NIH support, and the site footer shows a new revision tag (v3.6.6) replacing the previous version.
    Difference
    0.1%
    Check dated 2026-08-29T18:50:44.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, representing a minor maintenance/update to the page’s versioning. No study content is implied to have changed.
    Difference
    0.0%
    Check dated 2026-08-08T15:52:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.